{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:35:36Z","timestamp":1784864136604,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular disorder characterized by small, dilated clustered vessels (telangiectasias) and by larger visceral arteriovenous malformations (AVMs), which directly connect the feeding arteries with the draining veins. These lesions are fragile, prone to rupture, and lead to recurrent epistaxis and\/or internal hemorrhage among other complications. Germline heterozygous loss-of-function (LOF) mutations in Bone Morphogenic Protein 9 (BMP9) and BMP10 signaling pathway genes (endoglin-<jats:italic>ENG<\/jats:italic>, activin like kinase 1 <jats:italic>ACVRL1<\/jats:italic> aka <jats:italic>ALK1,<\/jats:italic> and <jats:italic>SMAD4<\/jats:italic>) cause different subtypes of HHT (HHT1, HHT2 and HHT-juvenile polyposis (JP)) and have a worldwide combined incidence of about 1:5000. Expert clinicians and international scientists gathered in Cascais,\u00a0Portugal from September 29th to October 2<jats:sup>nd<\/jats:sup>, 2022 to present the latest scientific research in the HHT field and novel treatment strategies for people living with HHT. During the largest HHT scientific conference yet, participants included 293 in person and 46 virtually. An impressive 209 abstracts were accepted to the meeting and 59 were selected for oral presentations. The remaining 150 abstracts were presented during judged poster sessions. This review article summarizes the basic and clinical abstracts selected as oral presentations with their new observations and discoveries as well as surrounding discussion and debate. Two discussion-based workshops were also held during the conference, each focusing on mechanisms and clinical perspectives in either AVM formation and progression or current and future therapies for HHT. Our hope is that this paper will represent the current progress and the remaining unanswered questions surrounding HHT, in order to serve as an update for those within the field and an invitation to those scientists and clinicians as yet outside of the field of HHT.<\/jats:p>","DOI":"10.1007\/s10456-023-09886-5","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:02:05Z","timestamp":1694419325000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Executive summary of the 14th HHT international scientific conference"],"prefix":"10.1007","volume":"26","author":[{"given":"Roxana","family":"Ola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-9893","authenticated-orcid":false,"given":"Josefien","family":"Hessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-4924","authenticated-orcid":false,"given":"Adrienne","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-316X","authenticated-orcid":false,"given":"Cassi","family":"Friday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9394-9271","authenticated-orcid":false,"given":"Marianne","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0968-7155","authenticated-orcid":false,"given":"Stryder","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-9319","authenticated-orcid":false,"given":"Vivek","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4474-9668","authenticated-orcid":false,"given":"Rosemary","family":"Akhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"issue":"3","key":"9886_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/biom10030488","volume":"10","author":"A Benn","year":"2020","unstructured":"Benn A et al (2020) BMP-SMAD1\/5 signaling regulates retinal vascular development. Biomolecules 10(3):488","journal-title":"Biomolecules"},{"issue":"1","key":"9886_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10456-022-09859-0","volume":"26","author":"H Choi","year":"2023","unstructured":"Choi H et al (2023) BMP10 functions independently from BMP9 for the development of a proper arteriovenous network. Angiogenesis 26(1):167\u2013186","journal-title":"Angiogenesis"},{"issue":"2","key":"9886_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10456-018-9602-0","volume":"21","author":"AM Crist","year":"2018","unstructured":"Crist AM et al (2018) Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia. Angiogenesis 21(2):363\u2013380","journal-title":"Angiogenesis"},{"issue":"4","key":"9886_CR4","first-page":"599","volume":"22","author":"AM Crist","year":"2019","unstructured":"Crist AM et al (2019) Angiopoietin-2 inhibition rescues arteriovenous malformation in a SMAD4 hereditary hemorrhagic telangiectasia mouse model. Angiogenesis 22(4):599\u2013599","journal-title":"Angiogenesis"},{"issue":"21","key":"9886_CR5","doi-asserted-by":"crossref","first-page":"e009514","DOI":"10.1161\/JAHA.118.009514","volume":"7","author":"YH Kim","year":"2018","unstructured":"Kim YH et al (2018) SMAD4 deficiency leads to development of arteriovenous malformations in neonatal and adult mice. J Am Heart Assoc 7(21):e009514","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"9886_CR6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","volume":"106","author":"M Mahmoud","year":"2010","unstructured":"Mahmoud M et al (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106(8):1425-U270","journal-title":"Circ Res"},{"key":"9886_CR7","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1038\/ncomms13650","volume":"7","author":"R Ola","year":"2016","unstructured":"Ola R et al (2016) PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 7:13650","journal-title":"Nat Commun"},{"issue":"21","key":"9886_CR8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1161\/CIRCULATIONAHA.118.033842","volume":"138","author":"R Ola","year":"2018","unstructured":"Ola R et al (2018) SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2. Circulation 138(21):2379\u20132394","journal-title":"Circulation"},{"issue":"10","key":"9886_CR9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.053047","volume":"144","author":"H Park","year":"2021","unstructured":"Park H et al (2021) Defective flow-migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 144(10):805\u2013822","journal-title":"Circulation"},{"issue":"2","key":"9886_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCRESAHA.119.315974","volume":"126","author":"S Tual-Chalot","year":"2020","unstructured":"Tual-Chalot S et al (2020) Loss of endothelial endoglin promotes high-output heart failure through peripheral arteriovenous shunting driven by VEGF signaling. Circ Res 126(2):243\u2013257","journal-title":"Circ Res"},{"issue":"7","key":"9886_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1083\/jcb.201603106","volume":"214","author":"N Baeyens","year":"2016","unstructured":"Baeyens N et al (2016) Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J Cell Biol 214(7):807\u201316","journal-title":"J Cell Biol"},{"issue":"11","key":"9886_CR12","first-page":"3487","volume":"119","author":"SO Park","year":"2009","unstructured":"Park SO et al (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119(11):3487\u20133496","journal-title":"J Clin Invest"},{"issue":"1","key":"9886_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","volume":"9","author":"G Lesca","year":"2007","unstructured":"Lesca G et al (2007) Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 9(1):14\u201322","journal-title":"Genet Med"},{"key":"9886_CR14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ncomms1633","volume":"3","author":"M Benzinou","year":"2012","unstructured":"Benzinou M et al (2012) Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia. Nat Commun 3:616","journal-title":"Nat Commun"},{"issue":"1","key":"9886_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66\u20137","journal-title":"Am J Med Genet"},{"issue":"10","key":"9886_CR16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2174\/138161206776361192","volume":"12","author":"P Giordano","year":"2006","unstructured":"Giordano P et al (2006) HHT in childhood: screening for special patients. Curr Pharm Des 12(10):1221\u20135","journal-title":"Curr Pharm Des"},{"key":"9886_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpeds.2018.01.079","volume":"197","author":"KS Pahl","year":"2018","unstructured":"Pahl KS et al (2018) Applicability of the curacao criteria for the diagnosis of hereditary hemorrhagic telangiectasia in the pediatric population. J Pediatr 197:207\u2013213","journal-title":"J Pediatr"},{"issue":"5","key":"9886_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings DA et al (2019) Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1. Am J Hum Genet 105(5):894\u2013906","journal-title":"Am J Hum Genet"},{"issue":"13","key":"9886_CR19","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/bloodadvances.2022007136","volume":"6","author":"KE Joyce","year":"2022","unstructured":"Joyce KE et al (2022) Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation. Blood Adv 6(13):3956\u20133969","journal-title":"Blood Adv"},{"issue":"6","key":"9886_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","volume":"2","author":"RH Wang","year":"2005","unstructured":"Wang RH et al (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2(6):399\u2013409","journal-title":"Cell Metab"},{"issue":"2","key":"9886_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48(2):73\u201387","journal-title":"J Med Genet"},{"issue":"12","key":"9886_CR22","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jvir.2019.05.028","volume":"30","author":"W Brinjikji","year":"2019","unstructured":"Brinjikji W et al (2019) Diagnostic yield of rescreening adults for pulmonary arteriovenous malformations. J Vasc Interv Radiol 30(12):1982\u20131987","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"9886_CR23","first-page":"534","volume":"18","author":"GA Latino","year":"2015","unstructured":"Latino GA et al (2015) Diagnostic yield of rescreening adults for pulmonary arteriovenous malformations. Angiogenesis 18(4):534\u2013535","journal-title":"Angiogenesis"},{"issue":"1","key":"9886_CR24","first-page":"131","volume":"21","author":"KL Mowers","year":"2018","unstructured":"Mowers KL et al (2018) Progression of pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia. Angiogenesis 21(1):131\u2013132","journal-title":"Angiogenesis"},{"issue":"1","key":"9886_CR25","first-page":"120","volume":"21","author":"I Vivek","year":"2018","unstructured":"Vivek I et al (2018) Diagnostic yield of rescreening adults for pulmonary arteriovenous malformations. Angiogenesis 21(1):120\u2013120","journal-title":"Angiogenesis"},{"issue":"6","key":"9886_CR26","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1183\/13993003.01588-2015","volume":"47","author":"VMM Vorselaars","year":"2016","unstructured":"Vorselaars VMM et al (2016) Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia. Eur Respir J 47(6):1750\u20131757","journal-title":"Eur Respir J"},{"issue":"3","key":"9886_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chest.2022.11.005","volume":"163","author":"J Hessels","year":"2023","unstructured":"Hessels J et al (2023) Evolution of pulmonary arteriovenous malformations: the role of contrast echocardiography. Chest 163(3):669\u2013677","journal-title":"Chest"},{"issue":"2","key":"9886_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.carj.2013.02.007","volume":"65","author":"K Hanneman","year":"2014","unstructured":"Hanneman K, Faughnan ME, Prabhudesai V (2014) Cumulative radiation dose in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. Can Assoc Radiol J 65(2):135\u201340","journal-title":"Can Assoc Radiol J"},{"issue":"5","key":"9886_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diii.2019.12.009","volume":"101","author":"J Greffier","year":"2020","unstructured":"Greffier J et al (2020) CT dose optimization for the detection of pulmonary arteriovenous malformation (PAVM): A phantom study. Diagn Interv Imaging 101(5):289\u2013297","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"9886_CR30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.chest.2019.11.023","volume":"157","author":"DM DePietro","year":"2020","unstructured":"DePietro DM et al (2020) Postembolotherapy pulmonary arteriovenous malformation follow-up: a role for graded transthoracic contrast echocardiography prior to high-resolution chest CT scan. Chest 157(5):1278\u20131286","journal-title":"Chest"},{"issue":"1","key":"9886_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2214\/AJR.21.27218","volume":"220","author":"MA Latif","year":"2023","unstructured":"Latif MA et al (2023) Postembolization persistence of pulmonary arteriovenous malformations: a retrospective comparison of coils and amplatzer and micro vascular plugs using propensity score weighting. AJR Am J Roentgenol 220(1):95\u2013103","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"9886_CR32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/jpm12071091","volume":"12","author":"SA Si-Mohamed","year":"2022","unstructured":"Si-Mohamed SA et al (2022) Embolization of recurrent pulmonary arteriovenous malformations by ethylene vinyl alcohol copolymer (Onyx((R))) in hereditary hemorrhagic telangiectasia: safety and efficacy. J Pers Med 12(7):1091","journal-title":"J Pers Med"},{"issue":"7","key":"9886_CR33","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.7326\/L21-0067","volume":"174","author":"ME Faughnan","year":"2021","unstructured":"Faughnan ME et al (2021) Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia RESPONSE. Ann Intern Med 174(7):1035\u20131036","journal-title":"Ann Intern Med"},{"issue":"16","key":"9886_CR34","doi-asserted-by":"crossref","first-page":"E1637","DOI":"10.1212\/WNL.0000000000200109","volume":"98","author":"E Winkler","year":"2022","unstructured":"Winkler E et al (2022) Endoluminal Biopsy for Molecular Profiling of Human Brain Vascular Malformations. Neurology 98(16):E1637\u2013E1647","journal-title":"Neurology"},{"issue":"18","key":"9886_CR35","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3390\/jcm11185280","volume":"11","author":"J Hessels","year":"2022","unstructured":"Hessels J et al (2022) Efficacy and safety of tacrolimus as treatment for bleeding caused by hereditary hemorrhagic telangiectasia: an open-label, pilot study. J Clin Med 11(18):5280","journal-title":"J Clin Med"},{"issue":"1","key":"9886_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s13023-022-02539-8","volume":"17","author":"KP Thompson","year":"2022","unstructured":"Thompson KP et al (2022) Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 17(1):405","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9886_CR37","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.ejmg.2021.104370","volume":"65","author":"CL Shovlin","year":"2022","unstructured":"Shovlin CL et al (2022) The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Eur J Med Genet 65(1):104370","journal-title":"Eur J Med Genet"},{"issue":"6","key":"9886_CR38","first-page":"577","volume":"59","author":"F Pagella","year":"2021","unstructured":"Pagella F et al (2021) Epidemiological, clinical and endoscopic features of epistaxis severity and quality of life in Hereditary haemorrhagic telangiectasia: a cross-sectional study. Rhinology 59(6):577\u2013584","journal-title":"Rhinology"},{"issue":"1","key":"9886_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13023-022-02426-2","volume":"17","author":"TTT Le","year":"2022","unstructured":"Le TTT et al (2022) Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT. Orphanet J Rare Dis 17(1):281","journal-title":"Orphanet J Rare Dis"},{"key":"9886_CR40","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1038\/hgv.2015.40","volume":"2","author":"F Hernandez","year":"2015","unstructured":"Hernandez F et al (2015) Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia. Hum Genome Var 2:15040","journal-title":"Hum Genome Var"},{"issue":"2","key":"9886_CR41","doi-asserted-by":"crossref","first-page":"e20191970","DOI":"10.1542\/peds.2019-1970","volume":"146","author":"JR Liu","year":"2020","unstructured":"Liu JR et al (2020) Homozygous GDF2-related hereditary hemorrhagic telangiectasia in a Chinese family. Pediatrics 146(2):e20191970","journal-title":"Pediatrics"},{"issue":"3","key":"9886_CR42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"WL Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue WL et al (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93(3):530\u2013537","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9886_CR43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajmg.a.62522","volume":"188","author":"A Farhan","year":"2022","unstructured":"Farhan A et al (2022) Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5. Am J Med Genet A 188(1):199\u2013209","journal-title":"Am J Med Genet A"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-023-09886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-023-09886-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-023-09886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:05:07Z","timestamp":1696118707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-023-09886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["9886"],"URL":"https:\/\/doi.org\/10.1007\/s10456-023-09886-5","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"12 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}